News | April 25, 2025
We’re working at full force to put Bayer back on a profitable growth path: Bill Anderson, CEO, Bayer
Bayer expects 2025 to be the most difficult year of its turnaround
Bayer expects 2025 to be the most difficult year of its turnaround
The partnership provides Sai Life Sciences with a greenhouse gas emissions reduction of up to 90% for its international logistics needs by using SAF
This unit will focus on the manufacturing of health and wellness equipment
The company is targeting a Rs. 1,000 crore finished dosages business within the next five years
Jobevne is a vascular endothelial growth factor (VEGF) inhibitor that binds with VEGF and blocks the interaction with its receptors to prevent angiogenesis
Asahi Kasei Life Science covers a broad range of bioprocess products and services
Founded in 2023, Spectrum Vascular acquired the vascular access businesses of Cook Medical in 2023 and AngioDynamics in 2024
Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy
Nadda noted that TB treatment coverage in India has increased from 59% to 85%
Over the last two years, Lupin has showcased exceptional improvement in its EcoVadis scoring
Subscribe To Our Newsletter & Stay Updated
